Andrew Cutler
Official BMW USA News Twitter account. Follow us for the latest news.
Articles
-
1 month ago |
hcplive.com | Andrew Cutler
Teva Pharmaceuticals announced new TEV- ‘749 data on March 31, 2025, finding that more than 90% of patients, 87% of nurses, and 73% of physicians reported satisfaction about the initiation regimen, monthly dosing schedule, and dosing options of this once-monthly subcutaneous olanzapine long-acting injectable (LAI) for schizophrenia.1,2 The survey was conducted via the phase 3 Subcutaneous Olanzapine Extended-Release Injection Study (SOLARIS), an 8-week, randomized (1:1:1), double-blind,...
-
1 month ago |
hcplive.com | Andrew Cutler
On March 31, 2025, Teva Pharmaceuticals announced more positive data on TEV- ‘749, a once-monthly subcutaneous olanzapine long-acting injectable (LAI) for schizophrenia: more than 92% of patients, 87% of nurses, and 73% of physicians reported being satisfied or very satisfied about TEV- ‘749’s initiation regimen, monthly dosing schedule, and dosing options.1 The attitudes and experiences survey was conducted within the successful Phase 3 Subcutaneous Olanzapine Extended-Release Injection...
-
2 months ago |
hmpgloballearningnetwork.com | Andrew Cutler |Roger S. McIntyre
Atypical antipsychotics can be associated with changes in metabolic parameters and weight gain in patients receiving adjunctive treatment to antidepressants for major depressive disorder (MDD). This video reviews the data on metabolic and weight changes from key clinical trials to help healthcare providers understand the potential impact. Watch the bipolar I disorder video here and the schizophrenia video here.
-
Jan 4, 2025 |
magicvalley.com | Andrew Cutler
In the blink of an eye, six months has elapsed since I took over as executive editor of the Times-News. Most days, especially early on, have a “drinking from the firehose” kind of feel to them as I try to remember the inner workings of the Times-News and get a feel for the community. But even as I swim upstream on most days, I have not been disappointed. The pace and intensity of the work has been invigorating.
-
Nov 30, 2024 |
magicvalley.com | Andrew Cutler
In the big scheme of things, the photo we printed on the front page of the sports section on Nov. 16 probably didn’t raise any eyebrows or trigger questions about journalism ethics. Yet the situation surrounding the photo is noteworthy for me, as executive editor, and a good place to stop and make a point I believe is relevant. The photo in question was an excellent shot taken by former Times-News photographer Pat Sutphin.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 235K
- Tweets
- 1K
- DMs Open
- No
RT @BMWUSgovaffairs: We were so pleased to have @EPAMichaelRegan join us for a preview of the BMW iX and BMW i4 and learn more on BMW Group…
Learn how the BMW Group feeds more renewable energy to the power grid. Tune in to #SAETomorrowToday @saeintl https://t.co/sP4JUxSLVU https://t.co/ix2Op7sLY4
Tune in to #SAETomorrowToday and meet Adam Langton, Energy Services Manager, Connected eMobility @BMWUSA & learn all about our ChargeForward program! @saeintl https://t.co/sP4JUxSLVU https://t.co/Ppz8vpEy89